These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29863873)

  • 1. Quantitative Proteomics of TRAMP Mice Combined with Bioinformatics Analysis Reveals That PDGF-B Regulatory Network Plays a Key Role in Prostate Cancer Progression.
    Zhang Y; Wang D; Li M; Wei X; Liu S; Zhao M; Liu C; Wang X; Jiang X; Li X; Zhang S; Bergquist J; Wang B; Yang C; Mi J; Tian G
    J Proteome Res; 2018 Jul; 17(7):2401-2411. PubMed ID: 29863873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathway.
    Liu F; Zhang Y; Men T; Jiang X; Yang C; Li H; Wei X; Yan D; Feng G; Yang J; Bergquist J; Wang B; Jiang W; Mi J; Tian G
    Oncotarget; 2017 Mar; 8(13):22059-22075. PubMed ID: 28423550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
    Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
    Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
    Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
    Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
    Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.
    Xu H; Jiang HW; Ding Q
    Actas Urol Esp; 2015 Apr; 39(3):161-8. PubMed ID: 25442907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.
    Farina NH; Zingiryan A; Akech JA; Callahan CJ; Lu H; Stein JL; Languino LR; Stein GS; Lian JB
    Oncotarget; 2016 Oct; 7(43):70462-70474. PubMed ID: 27634876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
    Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
    Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
    Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
    Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
    Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
    Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
    J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.
    Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R
    Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
    Sharma G; Singh RP; Agarwal R
    Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.